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Bluetongue (BT) is an insect-transmitted, economically important disease of domestic and
wild ruminants. Although only ﬁve of the 26 reported bluetongue virus (BTV) serotypes
are considered endemic to the USA, 10 exotic serotypes have been isolated primarily in the
southeastern region of the country since 1999. For an exotic BTV serotype to become
endemic there must be susceptible animal species and competent vectors. In the USA,
sheep and white-tailed deer (WTD) are the primary sentinel livestock and wildlife species,
respectively. In 2006, BTV-8 was introduced into Northern Europe and subsequently
overwintered, causing unprecedented livestock disease and mortality during the 2006–
2007 vector seasons. To assess the risk of the European strain of BTV-8 to North American
WTD, and understand the role they could play after a similar introduction, eight
bluetongue-seronegative WTD were inoculated with BTV-8. Body temperatures and
clinical signs were recorded daily. Blood samples were analyzed for BTV RNA with
quantitative real time reverse transcriptase polymerase chain reaction (qRT-PCR), serum
analyzed for BTV antibodies by cELISA, and tissues taken for histopathology and qRT-PCR.
All eight deer became infected and developed moderate to severe clinical disease from
days 8 to 15. Peak viremia was from day 7 to 10 with detectable titers through the end of
the study (28 days) in most deer. Serum antibody was detected by day 6, peaked by day 10
and continued through day 28. We conclude that North American WTD are highly
susceptible to BTV-8 and would act as clinical disease sentinels and amplifying hosts
during an outbreak.
Published by Elsevier B.V.
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1. Introduction
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Bluetongue virus (BTV) is an orbivirus that is transmitted by biting midges (Culicoides spp.) and causes transboundary, internationally reportable disease with high
morbidity and mortality in susceptible animal populations.
Serious economic impacts result directly from decreased
animal production, as well as indirectly from resulting
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regulatory repercussions. Bluetongue (BT) poses a constant
disease threat to the livelihood of livestock owners.
While Culicoides midges feed on numerous domestic
and wild ruminants (Tabachnick, 2004), BT in the USA is
largely a disease of sheep, cattle, deer (Odocoileus spp.) and
pronghorn antelope (Antilocapra americana). In domestic
animals, clinical disease is primarily seen in sheep and
includes fever, nasal lesions and discharge, excessive
salivation, anorexia, dehydration, depression, coronitis,
facial edema, conjunctivitis, cyanotic (blue) tongue, and
secondary pneumonia with up to 50% mortality (Parsonson, 1990). In wildlife, overt clinical disease is primarily
seen in white-tailed deer (WTD; O. virginianus) and
pronghorn antelope (Hoff and Trainer, 1978; Kocan
et al., 1987; Thorne et al., 1988; Stallknecht and Howerth,
2004). These wildlife species play important roles in the
epidemiology of BT outbreaks as sentinels, amplifying
hosts, and viral reservoirs in close proximity to sheep and
cattle grazing and watering areas. Similar to cattle, other
wild ruminant species may have histopathological indication of disease upon necropsy, but rarely show overt
clinical disease and are considered potential sub-clinical
viral reservoirs (Hoff and Trainer, 1972, 1978).
There are 26 reported serotypes of BTV, ﬁve of which
are considered endemic to the USA (BTV-2, 10, 11, 13, and
17) (Collisson and Barber, 1985). Morbidity and mortality
rates observed during outbreaks from different serotypes
are highly variable and with little to no serotype crossprotection reported to date using current vaccine technologies, vaccination must be serotype-speciﬁc (Noad and
Roy, 2009). The global distribution of BTV serotypes has
changed drastically in the past 15 years, possibly as a result
of climate change (Purse et al., 2005, 2008; Gale et al.,
2010). The rapid spread of BTV-8 throughout Northern
Europe in 2006–2007 is particularly alarming as the risk to
livestock and wildlife was thought to be minimal or nonexistent. This was the largest single serotype outbreak ever
recorded with devastating disease and mortality in sheep
and cattle. In Germany alone, the 2007 cases in cattle,
sheep and goats were 26,772, 32,116 and 209 with casefatality rates of 13%, 42% and 26%, respectively (Conraths
et al., 2009). It is estimated that the losses to the
agriculture industry was over 200 million Euros (Velthuis
et al., 2010).
The United States is at risk for similar incursions. Since
1999, 10 exotic BTV serotypes have been detected in the
southeastern region of the country: BTV-1, 3, 5, 6, 9, 12, 14,
19, 22, and 24 (Ostlund, 2010). Introduction of these new
serotypes may have resulted from the importation of
infected livestock (Hoar et al., 2004), or the arrival of
infected midges via wind currents (Sellers, 1980; Sellers
and Maarouf, 1989), shipping containers, or cargo holds of
ships as has been reported for some mosquito introductions (Linthicum et al., 2003; Furumizo et al., 2005).
In order to assess whether an exotic BTV introduction
into the USA will result in a widespread outbreak and
possibly become endemic, it is important to ascertain
whether the widely distributed, sentinel domestic (sheep)
and wildlife (WTD) ruminant species are susceptible. The
aim of this study was to determine the susceptibility of
WTD to the Northern European strain of BTV-8 to assess

the potential disease risk to this wildlife species and to
better understand the epidemiological role they would
play, should an introduction occur.

2. Materials and methods
2.1. Virus inoculum
Virus (BTV-8/NET2007/01) was obtained from the
Central Veterinary Institute of Wageningen University,
Lelystad, the Netherlands. The BTV-8 inoculum was EDTAblood harvested from Holstein Frisian cow NL441689187
from Bavel, Netherlands; the ﬁrst detected case of BTV-8
after overwintering (GenBank GQ506451–GQ506460)
(Backx et al., 2007). Brieﬂy, cell fractions of the harvested
EDTA-blood were washed three times with phosphate
buffered saline (PBS) containing 2% fetal bovine serum
(FBS; Sigma–Aldrich, St. Louis, MO, USA), resuspended in
the original volume, and stored in aliquots at 80 8C.
Because the viral inoculum was infected blood and a not
cell culture-adapted stock, it was necessary to use real time
qRT-PCR to determine the relative titer, rather than cell
culture titration methods. Mean threshold cycle (Ct) values
(triplicate) were compared to a dilution series of known
BTV stock to calculate RNA concentrations. Virus particle
determinations, relative to RNA concentrations, were then
calculated as described (Akita et al., 1992).
2.2. White-tailed deer (WTD)
Ten WTD fawns (2–14 days old) were obtained from a
private deer facility in Missouri, USA. Fawns were raised
and weaned at the Colorado State University (CSU), Animal
Population Health Institute’s Wildlife Research Facility,
Fort Collins, CO, USA. Animals were raised according to a
protocol approved by CSU’s Institutional Animal Care and
Use Committee (IACUC). Fawns were vaccinated subcutaneously (SC) with 1 ml Clostridium A toxoid (Novartis
Animal Health, Greensboro, North Carolina, USA),
dewormed with ivermectin (ProMectin1, Vedco, St.
Joseph, MO, USA; 0.2 mg/kg, SC), and fenbendazole
[Safe-guard1, Intervet/Schering-Plough, Summit, NJ,
USA; 5 mg/kg orally (PO)] and given a 4-day course of
sulfamethazine sodium (Sulmet1, Boehringer Ingelheim
Vetmedica, St. Joseph, MO, USA; 247.5 mg/kg day 1 and
then 123.75 mg/kg days 2–4 once a day PO) for treatment
and prevention of coccidiosis or other bacterial/parasitic
infections. At one month, weaning began and all animals
were given 3 ml Clostridium A toxoid as a SC booster.
Additionally, they were given a 7-way clostridial vaccine
(Ultrabac1 7; 2.5 ml SC) and tetanus toxoid (Colorado
Serum, Denver, CO, USA; 1 ml SC), again dewormed and
given anti-parasitic treatment with Ivermectin, sulfamethazine sodium, and fenbendazole. At approximately
9 months of age, the deer were sedated with an
intramuscular combination of medetomidine hydrochloride (Wildlife Pharmaceuticals Inc., Fort Collins, CO, USA;
0.1–0.2 mg/kg), azaperone (Wildlife Pharmaceuticals Inc.;
0.1–0.2 mg/kg), and butorphanol tartrate (Wildlife Pharmaceuticals Inc.; 0.22–0.34 mg/kg) and transported to the
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CSU, BSL-3 Animal Disease Laboratory, Fort Collins, CO,
USA.
2.3. Animal experiment
Eight BTV-seronegative deer were sedated with xylazine (1–2 mg/kg) and injected with BTV-8/NET2007/01
bovine blood stock virus subcutaneously in the neck (1 ml)
and inner left leg (1 ml). Two deer were sham inoculated
with PBS to serve as uninfected controls and housed with
infected animals to examine direct contact transmission.
Body temperatures and clinical signs (depression, loss of
appetite, oronasal discharge, respiratory distress, facial
edema) were scored using a scale from 0–3 (0 = absence;
1 = mild; 2 = moderate; 3 = severe) (van Gennip et al., 2012)
and recorded daily. Blood samples for cELISA and qRT-PCR
assays were taken at speciﬁc time points from all deer. Two
challenged animals were sedated with xylazine as above
and euthanized with pentobarbital (IV) at the anticipated
peak of viremia (day 8), two were euthanized for humane
reasons due to deteriorating clinical condition (one each on
day 12 and 15), and the remaining were held until day 28.
During necropsy, gross pathological ﬁndings were noted
and samples of liver, spleen, lung, heart, kidney, intestine,
mandibular lymph node, mesenteric lymph node, and
adrenal gland were collected and frozen for subsequent
qRT-PCR testing, or ﬁxed in 10% buffered formalin (Sigma–
Aldrich), embedded in parafﬁn (Fisher Scientiﬁc, Houston,
TX, USA) and sectioned (5 mm) for hematoxylin and eosin
(Fisher Scientiﬁc) histopathological analysis. All animal
manipulations were in compliance with the CSU IACUC
guidelines. All work with infected animals was performed
under BSL-3 containment conditions.
2.4. Real time PCR
Due to the unpassaged nature of this recent BTV-8
bovine virus isolate, cell culture-based titration assays
were not feasible. Thus, qRT-PCR was utilized as the
primary method to quantitate virus in the original
inoculum and in blood and tissue samples. Viral RNA
was extracted from blood using the MagMAXTM Blood RNA
Isolation Kit (Ambion, Austin, TX, USA) according to
manufacturer’s instructions and stored in round bottom
96-well plates at 80 8C. For tissue RNA, 50 mg of tissue
were individually homogenized by bead beating (TissueLyser, Qiagen, Germantown, MD, USA) in 500 ml PBS with
two 4.5 mm stainless steel ball bearings. Total RNA was
extracted from 100 ml of homogenate using the Total Viral
RNA Isolation Kit (Ambion) according to manufacturer’s
instructions and stored in round bottom 96-well plates at
80 8C.
Quantitative real-time reverse transcriptase PCR (qRTPCR) (Wilson et al., 2009) was performed on blood and
tissue RNA samples, in triplicate (Applied Biosystems
7500, Foster City, CA, USA). Reactions contained 5 ml
template and 20 ml master mix from Ag-Path IDTM RT-PCR
reagents (Ambion) for 40 cycles. BTV-8 was detected using
primer sequences speciﬁc for the S10 (NS3) and M5
(NS1) genes which are highly conserved within the
serogroup and highly expressed. Primer sequences were
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TTAAGCCTCCTAGGTCACTTTTCAA (forward), AAAGCTGCATTCGCATCGT
(reverse),
with
CACATCATCACGAAACGCTTCTGCG-50 CFO 560 and 30 BHQ-1 (probe) for
S10; GATTGCTTCACGGCCTCAT (forward), TTGGCAAAGGAGGCAATGT (reverse), with TGCACCCCGCACCGCTTC50 CFO 560 and 30 BHQ-1 (probe) for M5. Additionally, the
house-keeping gene b-actin was used as an internal, same
tube control using primers as previously described
(Moniwa et al., 2007). As above for the inoculum, mean
Ct values (triplicates) of the deer samples were compared
to known BTV stock concentrations to calculate RNA
concentrations. Virus particle determinations relative to
RNA concentrations were calculated as described (Akita
et al., 1992) and are reported as log10 particles/ml of blood
or tissue homogenate.
2.5. Detection of infectious virus
Due to the non-adapted nature of the BTV-8 inoculum
to cell culture systems, blind passages of virus from blood
samples were performed to obtain cytopathic effect (CPE)
and conﬁrm the infectious virus as the original viral
inoculum by qRT-PCR and sequence analysis. Day 8 blood
samples (1 ml each) from all inoculated deer were
sonicated (Q700; Qsonica, Newtown, CT, USA) for 3 min
with 5 s pulses at 100 mA and centrifuged for 10 min at
10,000  g. Cleared supernatants (500 ml) were used to
inoculate T-25 ﬂasks (Corning, Corning, NY, USA) containing baby hamster kidney (BHK; ATCC, Manassas, VA, USA)
cell monolayers grown in Dulbecco’s modiﬁed Eagle’s
medium (DMEM; Sigma–Aldrich) supplemented with 10%
FBS (Sigma–Aldrich) and 100 U/ml penicillin, 100 mg/ml
streptomycin sulfate (Sigma–Aldrich). Flasks were incubated at 37 8C for 5–7 days and examined for CPE. CPE
ﬂasks were freeze–thawed and 2 ml used to inoculate fresh
cells twice more for a total of three blind passages. A 1 ml
aliquot was used from each passage for RNA extraction and
BTV-8 qRT-PCR as described above. Additionally, viral RNA
was extracted, as above, from the blood of deer #15
(euthanized day 8) and the VP2 gene, which confers
serotype identity and has the most variable genomic
region among the serotypes (Roy, 2001), was sequenced
and compared with the original inoculum (Maan et al.,
2010; van Gennip et al., 2012). Four forward and three
reverse primers were used for full gene coverage. Forward
primers were VP2-1F ATGGAGGAGCTAGCGATTCCGAT;
VP2-620F AAATGCGGAACGTGCATCAACGAG; VP2-1356F
TGCGATCTGTTCCCTGAGGATGAA; and VP2-1972F AACACCCAACAATTGATCCCAGCG. Reverse primers were VP22903R CTATACATTGAGCAGCTTAGTTA; VP2-1837R CGCCTTGAAACAATCCCTGCGTAA; and VP2-643R CTCGTTGATGCACGTTCCGCATTT.
2.6. Serological analysis
Serum samples from experimentally infected deer were
tested for BTV antibody using a previously published
antigen capture enzyme-linked immunosorbent assay
(cELISA) (Mecham and Wilson, 2004). Brieﬂy, the wells
of Immunlon II microtiter plates (Dynatech Laboratories,
Inc., Chantilly, VA, USA) were coated overnight at 4 8C with
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polyclonal rabbit anti-BTV serum. Antigen was then
captured in the wells by addition of baculovirus expressed
BTV VP7 protein. Test serum samples, in triplicate, were
diluted 1:5 in PBS containing 0.1% bovine serum albumin
(BSA; Sigma–Aldrich) in the microtiter plate wells (ﬁnal
volume of 50 ml/well), followed by the addition of 50 ml/
well of diluted mouse monoclonal antibody speciﬁc for
VP7 of BTV. This was followed by sequential reactions with
biotinylated goat anti-mouse antibody (Biogenex, Fremont, CA, USA) and peroxidase-conjugated streptavidin
(Biogenex). Measurement of optical density (OD), following addition of ortho-phenylene diamine (OPD) substrate
(Sigma–Aldrich), was used to calculate percent inhibition
(PI): PI = 100  (OD492 nm test serum/OD492 nm negative
serum)  100. Pre-infection sera were used to determine
the OD negative serum values. Sera were also tested for
antibody to the related serologically cross-reactive epizootic hemorrhagic disease virus (EHDV), as determined
using an antigen-capture cELISA to that virus (Mecham and
Wilson, 2004).

hepatitis and mild, diffuse mononuclear interstitial pneumonia. Deer #6, euthanized at 15 dpi, had severe depression, loss of appetite, nasal discharge, excessive salivation,
respiratory distress, facial edema, low body temperature,
abnormal gait and loss of balance. Gross pathological
ﬁndings of these two deer was mild but consistent with
BTV infection and included hemorrhages in the spleen,
kidney, and intestine, interstitial edema in the lungs, and
mild accumulation of ﬂuid in the pericardium (deer #6
only). Histopathological ﬁndings included mild, chronic
portal hepatitis, mild white pulp lymphocytolysis and
lymphoid depletion of the spleen, and severe necrotizing
bronchopneumonia. No gross pathology was seen in deer
euthanized at 28 dpi (n = 4), the end of the experiment.
Clinical signs of disease were not observed in the two
sham inoculated negative control deer which were housed
with the inoculated deer. Additionally, no BTV RNA was
detected in blood or tissue samples conﬁrming, as
expected, that BTV-8 was not transmitted between WTD
by direct contact.

3. Results

3.2. Molecular analysis

3.1. Clinical observations

The BTV-8/NET2007/01 washed blood cell inoculum
was determined to be 5.78 log10 particles/ml (6  105/ml)
by qRT-PCR and RNA/virus particle determinations. Thus,
with the inoculation of 1 ml at two sites, the deer received
a total of 6.08 log10 particles (1.2  106). Viremia in
inoculated deer, as detected by qRT-PCR, started as early as
3 dpi, peaked from day 7 to 15 and persisted through day
28 in 3 of 4 surviving deer (Fig. 2). Blood virus titers in the
two deer euthanized on day 8 (#15 and #23) was 6.40 and
6.56 log10 particles/ml, respectively (Fig. 2A). Peak viremia
in the two deer euthanized during the peak of clinical
disease (#21 and #6) was 7.4 and 8 log10 particles/ml on 10
and 12 dpi, respectively (Fig. 2B). The highest viremia
detected at the end of the study (day 28) was 6.13 log10
particles/ml (deer #16; Fig. 2C).
As expected for a viremic infection, the distribution of
BTV-8 in tissues as detected by qRT-PCR was widespread. In
the two deer euthanized on day 8 (#15 and #23) viral RNA
was detected in all tissue homogenates tested (liver, spleen,
lung, heart, kidney, intestine, mandibular lymph node,
mesenteric lymph node, and adrenal gland). The highest
titers (log10 particles/ml of homogenate) for #15 and #23
were seen in the heart (7.64 and 5.73), lung (5.57 and 7.32),

Clinical signs in WTD were scored based on severity (van
Gennip et al., 2012) and included depression, loss of
appetite, nasal discharge, respiratory distress, facial edema,
conjunctivitis, conjunctival erythema, excessive salivation,
and elevated rectal temperatures (Table 1; Fig. 1). Clinical
disease peaked from 8 to 15 days post inoculation (dpi) and
was typically cleared by 21 dpi in surviving animals. Clinical
signs often associated with BT that were not seen in the
experimentally infected WTD included oronasal lesions,
coronitis, and cyanotic (blue) tongue.
Two randomly chosen deer (#15 and #23) were
euthanized during the anticipated peak of viremia
(8 dpi) to examine virus distribution in tissues. The livers
of both deer had mild, chronic portal hepatitis and
multifocal chronic interstitial nephritis and their lungs
had mild, diffuse mononuclear interstitial pneumonia.
Additionally, two deer (#21 and #6) had to be euthanized
during the peak of their clinical disease for humane
reasons. Deer #21, euthanized at 12 dpi, had severe nasal
discharge, excessive salivation, and respiratory distress.
Histopathological ﬁndings included mild, chronic portal

Table 1
Peak clinical signs from individual deer during challenge with serotype 8 of bluetongue virus.
Deer
6
7
14
15
16
20
21
23
a
b
c

Depression
a

3
2
0
0
0
2
2
0

Loss of appetite

Oronasal discharge

Respiratory distress

Facial edema

Temperature (8C)b

Peak viremia (log10/ml)c

3
3
3
0
3
3
3
0

2
0
1
0
0
0
3
0

1
0
1
0
0
2
3
0

3
2
2
0
0
1
3
0

40.6
39.6
40.1
41.2
39.6
40.8
40.6
40.2

7.0
7.0
6.4
6.4
6.7
6.7
6.4
6.6

Peak clinical signs using a scale from 0 to 3: 0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe condition.
Rectal temperatures in Celsius, average daily temp of control deer 39 8C.
Peak viremia as calculated by qRT-PCR.
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Fig. 1. Clinical bluetongue virus serotype 8 disease in white-tailed deer. (A) facial edema, excessive salivation, nasal discharge, conjunctival erythema (#21,
9 dpi; (B) anorexic, abnormal gait, loss of balance (#6, 15 dpi); (C) facial edema, conjunctival erythema (#21, 12 dpi; (D) respiratory distress as indicated by
open mouth breathing (#21, 12 dpi).

and liver (6.05 and 6.84), respectively (Fig. 3A). For the two
deer euthanized during the peak of their clinical disease
(#21 at 12 dpi and #6 at 15 dpi), viral RNA was detected in all
tissues tested with the highest titers (log10 particles/ml of
homogenate) seen in the spleen in both deer (9.62 and 8.98,
respectively) (Fig. 3B). At day 28, there was no consistent
pattern of viral tissue distribution and related viremia in the
four surviving BTV-8 inoculated deer. Viral RNA was
detected in only a single tissue in the three remaining
viremic deer; the spleen of #7 (5.47), the lung of #14 (5.18)
and the mesenteric lymph node of #16 (7.40 log10 particles/
ml) (Fig. 3C). Whereas, the deer with no detectable viremia
from day 21 through 28 (deer #20) showed the greatest
distribution of persisting viral RNA with detection in all
tissues tested except the intestine.

VP2 serotype speciﬁc gene obtained from the blood of deer
#15 (8 dpi) had 99.5% identity (100% similarity) to the
original BTV-8/NET2007/01 inoculum.
3.4. Serological analysis
Antibody speciﬁc to BTV was detected by the antigencapture cELISA in the serum of all experimentally infected
WTD (Fig. 4). Sera were scored positive for BTV antibody if
the PI was 50%, since a lower PI could increase the chance
of including false positives. Antibody responses in the WTD
were detected as early as 8 dpi and as late as 12 dpi, with
the majority of animals showing at least 70% cELISA
inhibition by 10 dpi. None of the experimental animals
were positive for antibody to the related serologically
cross-reactive EHDV (data not shown).

3.3. Virus isolation
4. Discussion
Infectious virus was isolated from the blood of all eight
inoculated deer in CPE ﬂasks and conﬁrmed as BTV-8 by
NS3 and NS1 qRT-PCR (data not shown). Additionally, a
2841 nucleotide sequence of the BTV-8 serotype speciﬁc

The recent incursion of BTV-8 into Northern Europe and
the UK has highlighted the risk that countries face for
accidental or intentional introductions of serotypes with

352

B.S. Drolet et al. / Veterinary Microbiology 166 (2013) 347–355

Fig. 2. Rectal temperatures (line) and viremia (bars) as detected by qRT-PCR of white-tailed deer inoculated with bluetongue virus serotype 8. Day of peak
clinical disease for each animal is indicated with an arrow. (A) Deer euthanized at 8 dpi (#15 and #23) during the expected peak of viremia; (B) deer
euthanized at 12 dpi (#21) and 15 dpi (#6) during the peak of clinical disease; (C) deer euthanized at 28 dpi. Normal temperature 39 8C (asterisk).

unknown virulence into naı̈ve domestic and wild ruminant
herds. With varying virulence, and little to no cross
protection between outbreak isolates, the 26 serotypes of
BTV are a constant disease threat to North American
livestock and wildlife. Susceptible hosts and Culicoides
competent for the endemic BTV serotypes are found

throughout the country which results in an environment
very favorable for the already identiﬁed (Ostlund, 2010) or
new exotic isolates to become established upon introduction via infected midge or animal.
Because BTV vectors (Culicoides spp.) feed on both wild
and domestic ruminants, the wildlife-livestock interface is
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Fig. 4. Antibody response as detected by competitive ELISA in serum of
white-tailed deer inoculated with bluetongue virus serotype 8. Deer #15
and #23 were euthanized on day 8; deer #21 on day 12; deer #6 on day
15; deer #7, 14, 16, and 20 on day 28. Deer #8 and #13 (negative controls)
were euthanized on day 28. Sera were scored positive for BTV antibody if
the PI was 50%. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of the article.)

Fig. 3. Distribution of bluetongue virus serotype 8 in tissues of
experimentally infected white-tailed deer as detected by qRT-PCR. (A)
Deer euthanized at 8 dpi (#15 and #23) during the peak of viremia; (B)
deer euthanized at 12 dpi (#21) and 15 dpi (#6) during the peak of clinical
disease; (C) deer euthanized at 28 dpi. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the
web version of the article.)

a critical factor in the epidemiology of outbreaks and risk
assessment in terms of viral ampliﬁcation and geographic
distribution (Drolet et al., 1990; Garcia et al., 2009; GarciaBocanegra et al., 2011). This is the ﬁrst report of
experimental infection of North American WTD with the
European strain of BTV-8. Our ﬁndings demonstrate that
BTV-8 infection produces moderate to severe clinical
disease and that during the peak of both viremia and
clinical disease, virus is widespread in tissues. At peak
clinical disease (deer #6 and #21), titers of virus as
detected by qRT-PCR were higher in some tissues than in
the blood. This was especially the case for deer #21 with
from 3.5 (lung) to 344 (spleen) times more virus in 1 ml of
tissue homogenate than 1 ml of blood at the time of

necropsy. These results suggest active virus replication in
several tissues at the peak of clinical disease.
Of the four surviving deer at day 28, three had
detectable viremia. However, ﬂuctuations during the 28day study, as well as animal to animal variation were seen.
In deer #20, viral RNA persisted in all tissues except the
intestine without a corresponding viremia. A drop in
viremia was also seen in deer #14 and #16 from 17 to 24
days followed by a recovery on day 28. This trend may
suggest a cyclical viremia where virus or viral RNA
persisted in some tissues, but was shed and cleared in
peripheral blood intermittently after peak clinical disease.
Oscillating patterns of BTV viremia, as detected by qRTPCR, have also been shown in sheep (Batten et al., 2012),
cattle (Di Gialleonardo et al., 2011) and camels (Batten
et al., 2011). A longer term study would be required to
ascertain this trend and whether it may have diagnostic
implications where virus persists in the absence of viremia.
It is possible that immune responses may inﬂuence tissue
and blood clearance of virus, but the mechanistic basis for
this variable immunity is not understood.
Although seroprevalence studies of wildlife in European outbreak areas have shown the presence of BTV-8
speciﬁc antibody in red (Cervus elaphus), fallow (Dama
dama) and roe (Capreolus capreolus) deer, little to no
disease was observed suggesting these wildlife species
may have acted as subclinical reservoirs (Linden et al.,
2008; Conraths et al., 2009; Garcia et al., 2009; Falconi
et al., 2011; Garcia-Bocanegra et al., 2011). This was
substantiated in experimental BTV-8 infections of red deer
(Lopez-Olvera et al., 2010; Lorca-Oro et al., 2012) and is
similar to seroprevalence reports and ﬁeld observations for
BTV-4 in Spain (Ruiz-Fons et al., 2008; Rodriguez-Sanchez
et al., 2010; Garcia-Bocanegra et al., 2011).
In general, North American WTD appear to be much
more susceptible to BTV infection and development of
clinical disease (Howerth et al., 1988; Parsonson, 1990;
Quist et al., 1997; Stallknecht and Howerth, 2004) than
Eurasian deer species as described above. Prior to this
study, however, it was not clear whether infection of WTD
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with the European strain of BTV-8 would result in
subclinical disease as seen in Europe, clinical disease
similar to North American domestic serotypes, or more
severe disease levels. Falconi et al. (2011) reported that
BTV serotype 8 had previously been shown to cause clinical
disease in WTD. Their referenced report (Vosdingh et al.,
1968) actually states that BTV-8 ‘‘strain’’ was used, not BTV
serotype 8. This was the California BTV strain 8 isolate from
USDA-ARS, which subsequently typed as BTV-10 (Yu et al.,
1987). More recent reports using this strain refer to it as
‘‘CA-8 BTV-10’’ or ‘‘BTV-10; BT-8 strain’’ (Wilson et al.,
1990). Thus, this is the ﬁrst report of experimental
infection of North American white-tailed deer with BTV
serotype 8.
For this study, the BTV-8 inoculum used was infected
bovine blood from the ﬁrst detected 2007 case of BTV-8 in
the Netherlands after overwintering. Although more
difﬁcult to work with in some respects, recent isolates
from naturally infected animals are desirable for animal
infection studies, as there can be some degree of
conﬁdence that cell passage-associated mutations and in
vitro ﬁtness selection have not occurred and will not affect
the resulting infectious process. However, the lack of being
cell culture adapted makes cell culture-based titrations of
blood and tissues impossible. In terms of epidemiological
predictions, care should always be taken in extrapolating
qRT-PCR quantitation and subsequent particle calculations
to infectious virus titers and duration of viremia.
Understanding the degree to which our wildlife and
livestock species are susceptible to BTV-8 is critical in
determining relevant epidemiological assessments and
risk analyses for the USA. WTD are the wildlife species
most often affected by endemic serotypes of BTV, and are
therefore the likely wildlife species to play a role in the
ability of BTV-8 to become established. Although more
clinical disease was observed in WTD compared to that
seen with both natural (Conraths et al., 2009; Falconi et al.,
2011; Garcia-Bocanegra et al., 2011) and experimental
(Lopez-Olvera et al., 2010; Lorca-Oro et al., 2012) infection
of Eurasian deer species, it was consistent with BT disease
levels previously reported for North American domestic
serotypes (Hoff and Trainer, 1978; Stallknecht et al., 1995;
Quist et al., 1997). Our ﬁndings suggest that should BTV-8
be introduced in the USA, WTD would be expected to act as
clinical disease sentinels and survival rates would be
sufﬁciently high to act as signiﬁcant virus amplifying
reservoirs for subsequent transmission of virus by
Culicoides spp. to livestock and other wildlife species.
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